Exposure to bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3405-3416

  Jelacic, Tanya M ^a   Chabot, Donald J ^a   Bozue, Joel A ^a   Tobery, Steven A ^a   West, Michael W ^a   Moody, Krishna ^c   Yang, De ^b   Oppenheim, Joost J ^b   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL CAPSULE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENDRITIC CELL; ENVIRONMENTAL EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INNATE IMMUNITY; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELLS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION;

BACILLUS ANTHRACIS; BACTERIAL CAPSULES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-6; INTERLEUKIN-8;

EID: 84904724085     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01857-14     Document Type: Article

References (47)

1. Mikesell P, Ivins BE, Ristroph JD, Dreier TM. 1983. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect. Immun. 39:371-376.
2. Green BD, Battisti L, Koehler TM, Thorne CB, Ivins BE. 1985. Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49: 291-297.
3. Uchida I, Sekizaki T, Hashimoto K, Terakado N. 1985. Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J. Gen. Microbiol. 131:363-367.
4. Makino S, Uchida I, Terakado N, Sasakawa C, Yoshikawa M. 1989. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171:722-730.
5. Scorpio A, Chabot DJ, Day WA, O'Brien DK, Vietri NJ, Itoh Y, Mohamadzadeh M, Friedlander AM. 2007. Poly-_-glutamate capsuledegrading enzyme treatment enhances phagocytosis and killing of encap- sulated Bacillus anthracis. Antimicrob. Agents Chemother. 51:215-222. http://dx.doi.org/10.1128/AAC.00706-06.
6. Keppie J, Harris-Smith PW, Smith H. 1963. The chemical basis of the virulence of Bacillus anthracis. IX. Its aggressins and their mode of action. Br. J. Exp. Pathol. 44:446-453.
7. Zwartouw HT, Smith H. 1956. Polyglutamic acid from Bacillus anthracis grown in vivo: structure and aggressin activity. Biochem. J. 63:437-442.
8. Goodman JW, Nitecki DE. 1967. Studies on the relation of a prior immune response to immunogenicity. Immunology 16:577-583.
9. Wang TT, Lucas AH. 2004. The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen. Infect. Immun. 72:5460-5463. http: //dx.doi.org/10.1128/IAI.72.9.5460-5463.2004.
10. Kozel TR, Murphy WJ, Brandt S, Blazar BR, Lovchik JA, Thorkildson P, Percival A, Lyons CR. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. U. S. A. 101:5042-5047. http://dx.doi.org/10.1073/pnas .0401351101.
11. Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR. 2009. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect. Immun. 77:3432-3441. http://dx.doi.org/10.1128 /IAI.00346-09.
12. Sutherland MD, Thorkildson P, Parks SD, Kozel TR. 2008. In vivo fate and distribution of poly-_-D-glutamic acid, the capsular antigen from Bacillus anthracis. Infect. Immun. 76:899-906. http://dx.doi.org/10.1128 /IAI.01176-07.
13. Roelants GE, Whitten LF, Hobson A, Goodman JW. 1969. Immunochemical studies on the poly-_-D-glutamyl capsule of Bacillus anthracis. J. Immunol. 103:937-943.
14. Smith H, Gallop RC. 1956. The chemical basis of the virulence of Bacillus anthracis. VI: an extracellular immunising aggressin isolated from exudates of infected guinea-pigs. Br. J. Exp. Pathol. 37:144-155.
15. Makino S, Watarai M, Cheun H, Shirahata T, Uchida I. 2002. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J. Infect. Dis. 186:227-233. http: //dx.doi.org/10.1086/341299.
16. Tournier J, Paccani SR, Quesnel-Hellman A, Baldari CT. 2009. Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol. Aspects Med. 30:456-466. http://dx.doi.org/10.1016/j.mam.2009 .06.002.
17. Menard R, Sansonetti PJ, Parsot C. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
18. Bozue JA, Parthasarathy N, Phillips LR, Cote CK, Fellows PF, Mendelson I, Shafferman A, Friedlander AM. 2005. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb. Pathog. 38:1-12. http://dx.doi.org/10 .1016/j.micpath.2004.10.001.
19. Mendelson I, Tobery S, Scorpio A, Bozue J, Shafferman A, Friedlander AM. 2004. The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence. Microb. Pathog. 37:149-154. http://dx.doi.org/10.1016/j .micpath.2004.06.008.
20. Cote CK, Bozue J, Moody KL, DiMezzo TL, Chapman CE, Welkos SL. 2008. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization. Microbiology 154:619-632. http://dx.doi.org /10.1099/mic.0.2007/008292-0.
21. Scorpio A, Chabot DJ, Day WA, Hoover TA, Friedlander AM. 2010. Capsule depolymerase overexpression reduces Bacillus anthracis virulence. Microbiology 156:1459-1467. http://dx.doi.org/10.1099/mic.0 .035857-0.
22. Candela T, Fouet A. 2005. Bacillus anthracis CapD, belonging to the _-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol. Microbiol. 57:717-726. http://dx.doi.org /10.1111/j.1365-2958.2005.04718.x.
23. Langer M, Malykhin A, Maeda K, Chakrabarty K, Williamson KS, Feasley CL, West CM, Metcalf JP, Coggeshall KM. 2008. Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway. PLoS One 3:e3706. http://dx.doi.org/10.1371/journal.pone.0003706.
24. Richter S, Anderson VJ, Garufi G, Lu L, Budzik JM, Joachimiak A, He C, Schneewind O, Missiakas D. 2009. Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin. Mol. Microbiol. 71:404-420. http://dx.doi.org/10.1111/j.1365-2958 .2008.06533.x.
25. Iyer JK, Khurana T, Langer M, West CM, Ballard JD, Metcalf JP, Merkel TJ, Coggeshall KM. 2010. Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal trafficking. Infect. Immun. 78:2418-2428. http://dx.doi.org/10.1128/IAI .00170-10.
26. Barua S, Iyer JK, Larabee JL, Raisley B, Hughes MA, Coggeshall KM, Ballard JD. 2013. Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood. Infect. Immun. 81: 3693-3702. http://dx.doi.org/10.1128/IAI.00709-13.
27. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, Van Dijk H. 1993. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-_, interleukin-1 _, and interleukin-6. FEMS Immunol. Med. Microbiol. 7:281-287. http://dx .doi.org/10.1111/j.1574-695X.1993.tb00409.x.
28. Wang JE, Dahle MK, McDonald M, Foster SJ, Aasen AO, Thiemermann C. 2003. Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 20: 402-414. http://dx.doi.org/10.1097/01.shk.0000092268.01859.0d.
29. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. http://dx.doi.org/10.1038/32588.
30. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y. 1998. EB11/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161:3096-3102.
31. Müller G, Lipp M. 2003. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 10:325- 334. http://dx.doi.org/10.1080/mic.10.3-4.325.334.
32. Cho M, Ahn H, Ha H, Park J, Chun J, Kim B, Oh H, Rhie G. 2010. Bacillus anthracis capsule activates caspase-1 and induces interleukin-1_ release from differentiated THP-1 and human monocyte-derived dendritic cells. Infect. Immun. 78:387-392. http://dx.doi.org/10.1128/IAI .00956-09.
33. Weiss S, Levy H, Fisher M, Kobiler D, Altboum Z. 2009. Involvement of TLR2 in innnate response to Bacillus anthracis infection. Innate Immun. 15:43-51. http://dx.doi.org/10.1177/1753425908100379.
34. Hegde S, Pahne J, Smola-Hess S. 2004. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-_B binding activity and CCR7 expression. FASEB J. 18:1439-1441. http://dx.doi.org/10 .1096/fj.03-0969fje.
35. Sanchez-Sanchez N, Riol-Blanco L, de la Rosa G, Puig-Kroger A, Garcia-Bordas J, Martin D, Longo N, Cuadrado A, Cabanas C, Corbi AL, Sanchez-Mateos P, Rodriguez-Fernandez JL. 2004. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104:619-625. http://dx.doi.org/10.1182/blood -2003-11-3943.
36. Escribano C, Delgado-Martin C, Rodriguez-Fernandez JL. 2009. CCR7- dependent stimulation of survival in dendritic cells involves inhibition of GSK3_. J. Immunol. 183:6282- 6295. http://dx.doi.org/10.4049 /jimmunol.0804093.
37. Glomski IJ, Corre J, Mock M, Goossens PL. 2007. Cutting edge: IFN-_- producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J. Immunol. 178:2646-2650. http://dx.doi.org /10.4049/jimmunol.178.5.2646.
38. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. 2003. The dual role of IL-10. Trends Immunol. 24:36-43. http://dx.doi.org/10.1016 /S1471-4906(02)00009-1.
39. Schulz U, Kreutz M, Multhoff G, Stoelcker B, Kohler M, Andreesen R, Holler E. 2010. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Scand. J. Immunol. 72:319-331. http://dx.doi.org/10.1111/j.1365-3083.2010.02435.x.
40. Gonzales CM, Williams CB, Calderon VE, Huante MB, Moen ST, Popov VL, Baze WB, Peterson JW, Endsley JJ. 2012. Antibacterial role for natural killer cells in host defense to Bacillus anthracis. Infect. Immun. 80:234-242. http://dx.doi.org/10.1128/IAI.05439-11.
41. Klezovich-Benard M, Corre J, Jusforgues-Saklani H, Fiole D, Burjek N, Tournier J, Goossens PL. 2012. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog. 8:e1002481. http://dx.doi .org/10.1371/journal.ppat.1002481.
42. Hong C, Nam AS, Keller HR, Ligons DL, Park J, Yoon H, Park JJ, Luckey MA, Park J. 2013. Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine 64:532-540. http://dx.doi.org/10.1016/j.cyto .2013.08.001.
43. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28:445-489. http://dx.doi.org/10 .1146/annurev-immunol-030409-101212.
44. McGeachy MJ, McSorley SJ. 2012. Microbial-induced Th17: superhero or supervillain? J. Immunol. 189:3285-3291. http://dx.doi.org/10.4049 /jimmunol.1201834.
45. Gaffen SL. 2011. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23:613-619. http://dx.doi.org/10.1016/j.coi.2011.07.006.
46. Curtis MM, Way SS. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177-185. http://dx.doi.org/10.1111/j.1365-2567.2008.03017.x.
47. Hahn AC, Lyons CR, Lipscomb MF. 2008. Effect of Bacillus anthracis virulence factors on human dendritic cell activation. Hum. Immunol. 69:552-561. http://dx.doi.org/10.1016/j.humimm.2008.06.012.